Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| Shuttle Pharmaceuticals Holdings, Inc.SHPH · Entity 8505 | Chief Financial Officer | August 08, 2025 | August 12, 2025 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
Shuttle Pharmaceuticals Holdings, Inc.
Report date August 08, 2025 · Filed August 12, 2025
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Restricted Stock UnitSEC Table II · derivative / convertible security | Direct | 29,240 |
Reported balance
After 2025-08-08 transaction · row 1
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 1 · 2025-08-08 · Grant · Acquired 29,240 · Balance 29,240 F1: Each Restricted Stock Unit ("RSU"s) represents the contingent right to receive one share of common stock. F2: One-third of these RSUs will vest on each of 08/08/2026, 08/08/2027 and 08/08/2028. |
| Restricted Stock UnitSEC Table II · derivative / convertible security | Direct | 24,854 |
Reported balance
After 2025-08-08 transaction · row 2
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 2 · 2025-08-08 · Grant · Acquired 24,854 · Balance 24,854 F1: Each Restricted Stock Unit ("RSU"s) represents the contingent right to receive one share of common stock. F3: These RSUs will vest on 02/08/2026. |
Filing footnotes · ownership attribution and instrument terms
F1: Each Restricted Stock Unit ("RSU"s) represents the contingent right to receive one share of common stock.
F2: One-third of these RSUs will vest on each of 08/08/2026, 08/08/2027 and 08/08/2028.
F3: These RSUs will vest on 02/08/2026.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| August 08, 2025 Filed Aug 12, 2025 21:22 UTC | Shuttle Pharmaceuticals Holdings, Inc. SHPH · Entity 8505 | GrantRestricted Stock Unit · Derivative | 24,854 | $0.00 | $0.00 |
DisclosureSEC source: 0001641172-25-023275 · ownership.xml · derivative · entry 2 Lorber Timothy J. · CIK 0002027850 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 24,854 Underlying: Common Stock · 24,854 shares Expires not disclosed F1 · derivative.exercise_price: Each Restricted Stock Unit ("RSU"s) represents the contingent right to receive one share of common stock. F3 · derivative.exercise_date: These RSUs will vest on 02/08/2026. F3 · derivative.expiration_date: These RSUs will vest on 02/08/2026. Read SEC document |
| August 08, 2025 Filed Aug 12, 2025 21:22 UTC | Shuttle Pharmaceuticals Holdings, Inc. SHPH · Entity 8505 | GrantRestricted Stock Unit · Derivative | 29,240 | $0.00 | $0.00 |
DisclosureSEC source: 0001641172-25-023275 · ownership.xml · derivative · entry 1 Lorber Timothy J. · CIK 0002027850 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 29,240 Underlying: Common Stock · 29,240 shares Expires not disclosed F1 · derivative.exercise_price: Each Restricted Stock Unit ("RSU"s) represents the contingent right to receive one share of common stock. F2 · derivative.exercise_date: One-third of these RSUs will vest on each of 08/08/2026, 08/08/2027 and 08/08/2028. F2 · derivative.expiration_date: One-third of these RSUs will vest on each of 08/08/2026, 08/08/2027 and 08/08/2028. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.